TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 71 filers reported holding TREACE MED CONCEPTS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,619 | -35.4% | 3,556 | +26.0% | 0.02% | -34.3% |
| Q2 2023 | $72,212 | +1.5% | 2,823 | 0.0% | 0.04% | -7.9% |
| Q1 2023 | $71,111 | +26.0% | 2,823 | +15.0% | 0.04% | +15.2% |
| Q4 2022 | $56,417 | +4.5% | 2,454 | 0.0% | 0.03% | +3.1% |
| Q3 2022 | $54,000 | +100.0% | 2,454 | +28.7% | 0.03% | +88.2% |
| Q2 2022 | $27,000 | -25.0% | 1,907 | 0.0% | 0.02% | -5.6% |
| Q1 2022 | $36,000 | -12.2% | 1,907 | -14.3% | 0.02% | -5.3% |
| Q4 2021 | $41,000 | -31.7% | 2,225 | 0.0% | 0.02% | -48.6% |
| Q3 2021 | $60,000 | +46.3% | 2,225 | +68.8% | 0.04% | +48.0% |
| Q2 2021 | $41,000 | – | 1,318 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |